30
Participants
Start Date
March 31, 2010
Primary Completion Date
April 30, 2011
Study Completion Date
April 30, 2011
ZOLPIDEM
Pharmaceutical form: tablet Route of administration: oral Dose regimen: once daily
Investigational Site Number 10, Buenos Aires
Investigational Site Number 1, C.a.b.a.
Investigational Site Number 4, C.a.b.a.
Investigational Site Number 6, C.a.b.a.
Investigational Site Number 3, La Plata
Investigational Site Number 2, Capital Federal
Lead Sponsor
Sanofi
INDUSTRY